Introduction: Given the role of platelets in thrombus formation, markers of platelet activation may be able to predict outcomes in patients with acute pulmonary thromboembolism (PTE). Methods: In a prospective cohort study, 492 patients with acute PTE were enrolled. Patients were evaluated for platelet indices including mean platelet volume (MPV), platelet distribution width (PDW), and platelet-lymphocyte-ratio (PLR), as well as for the simplified Pulmonary Embolism Severity Index (PESI) risk score. The primary endpoint was in-hospital all-cause mortality. Major adverse cardiopulmonary events (MACPE, composite of mortality, thrombolysis, mechanical ventilation and surgical embolectomy during index hospitalization) and all-cause death during follow-up were secondary endpoints. Results: MPV, PDW and PLR were 9. 9± 1. 0 fl, 13. 5± 6. 1%, and 14. 7± 14. 5, respectively, in the total cohort. Whilst MPV was higher in those with adverse events (10. 1± 1. 0 vs 9. 9± 1. 0 fl; P = 0. 019), PDW and PLR were not different between two groups. MPV with a cut-off point of 9. 85 fl had a sensitivity of 81% and a specificity of 50% in predicting in-hospital mortality, but it had lower performance in predicting MACPE (Area under the curve: AUC 0. 58; 95%CI 0. 52-0. 63) or long-term mortality (AUC 0. 54; 95% CI 0. 47-0. 61). The AUC for all these three markers were lower than the AUC calculated for the simplified PESI score (0. 80; 0. 71-0. 88). Conclusion: Platelet indices had only fair-to-good predictive performance in predicting in-hospital all-cause death. Established PTE risk scoring models such as simplified PESI outperform these indices in predicting adverse outcomes.